Tenajora, Merina A.

HRN: 06-15-07  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/25/2023
10/02/2023
IV
2.25gm
Q6H
CAP MR; PTB
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: